Literature DB >> 9127419

Pediatric ECMO for severe quinidine cardiotoxicity.

F W Tecklenburg1, N J Thomas, S A Webb, C Case, D M Habib.   

Abstract

We report the use of extracorporeal membrane oxygenation (ECMO) to establish and maintain cardiovascular stability in a 16 month old with refractory bradydysrrhythmias and hypotension after an acute overdose of quinidine. He underwent an 11-day course of ECMO and was discharged with normal neurologic function. This case illustrates the role ECMO can play in the treatment of profound cardiovascular collapse caused by toxic ingestions. To be optimally effective, management of such patients must be anticipatory.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127419     DOI: 10.1097/00006565-199704000-00007

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

Review 1.  Mechanical cardiopulmonary support in children and young adults: extracorporeal membrane oxygenation, ventricular assist devices, and long-term support devices.

Authors:  A C Chang; E D McKenzie
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

Review 2.  Pediatric cardiopulmonary resuscitation: advances in science, techniques, and outcomes.

Authors:  Alexis A Topjian; Robert A Berg; Vinay M Nadkarni
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

3.  EGD for Refractory Toxidromes: Is It Time to Add to the Algorithm?

Authors:  Kelsey Allen; Ian Kane; Nicholas Connors; Frederick Tecklenburg; Whitney Marvin
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

4.  Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases.

Authors:  Cédric Daubin; Philippe Lehoux; Calin Ivascau; Marine Tasle; Mehdi Bousta; Olivier Lepage; Charlotte Quentin; Massimo Massetti; Pierre Charbonneau
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

Review 5.  Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity.

Authors:  Frédéric J Baud; Bruno Megarbane; Nicolas Deye; Pascal Leprince
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.